George Fromm

1.4k total citations
21 papers, 671 citations indexed

About

George Fromm is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, George Fromm has authored 21 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Oncology. Recurrent topics in George Fromm's work include Genomics and Chromatin Dynamics (7 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). George Fromm is often cited by papers focused on Genomics and Chromatin Dynamics (7 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). George Fromm collaborates with scholars based in United States, United Kingdom and France. George Fromm's co-authors include Michael Bulger, Karen Adelman, David C. Fargo, Adam Burkholder, Taylor H. Schreiber, Suresh de Silva, Kathleen E. McGrath, James Palis, Jenna M. Frame and Telmo Henriques and has published in prestigious journals such as Cell, Genes & Development and Blood.

In The Last Decade

George Fromm

21 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Fromm United States 13 415 190 119 91 62 21 671
Iryna Lebedyeva United States 16 342 0.8× 125 0.7× 129 1.1× 64 0.7× 115 1.9× 35 623
Jörg Hartkamp Germany 11 426 1.0× 66 0.3× 130 1.1× 56 0.6× 63 1.0× 16 541
Keyi Zhu United States 7 375 0.9× 87 0.5× 163 1.4× 50 0.5× 114 1.8× 10 524
Joseph Wynne United States 8 262 0.6× 89 0.5× 83 0.7× 63 0.7× 98 1.6× 13 493
Valgarður Sigurðsson Sweden 12 279 0.7× 78 0.4× 181 1.5× 82 0.9× 102 1.6× 22 540
Kiran Nakka Canada 13 500 1.2× 67 0.4× 82 0.7× 41 0.5× 148 2.4× 18 642
Archana Mukhopadhyay United States 6 433 1.0× 51 0.3× 69 0.6× 73 0.8× 42 0.7× 10 510
Svetlana Stoykova United States 4 626 1.5× 70 0.4× 141 1.2× 128 1.4× 217 3.5× 5 898
Cheryl McFarlane United Kingdom 14 460 1.1× 102 0.5× 246 2.1× 132 1.5× 128 2.1× 19 680
Sho Kubota Japan 16 369 0.9× 65 0.3× 122 1.0× 74 0.8× 80 1.3× 46 552

Countries citing papers authored by George Fromm

Since Specialization
Citations

This map shows the geographic impact of George Fromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Fromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Fromm more than expected).

Fields of papers citing papers by George Fromm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Fromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Fromm. The network helps show where George Fromm may publish in the future.

Co-authorship network of co-authors of George Fromm

This figure shows the co-authorship network connecting the top 25 collaborators of George Fromm. A scholar is included among the top collaborators of George Fromm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Fromm. George Fromm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Anne Y., Chunyan Wang, Dana C. Baiu, et al.. (2024). Abstract 6722: A CD33 antigen targeted Gamma Delta T-cell engager in combination with zoledronate promotes Vg9Vd2+ T cell proliferation and cytotoxicity against acute myeloid leukemia. Cancer Research. 84(6_Supplement). 6722–6722. 1 indexed citations
2.
Fromm, George, Suresh de Silva, & Taylor H. Schreiber. (2023). Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists. Frontiers in Immunology. 14. 1236332–1236332. 8 indexed citations
3.
Shuptrine, Casey W., et al.. (2023). Shining a LIGHT on myeloid cell targeted immunotherapy. European Journal of Cancer. 187. 147–160. 9 indexed citations
4.
Patel, Arpita, Kellsey Johannes, Louis Gonzalez, et al.. (2022). Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D. The Journal of Immunology. 209(8). 1475–1480. 17 indexed citations
5.
Johannes, Kellsey, Louis Gonzalez, Arpita Patel, et al.. (2022). LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade. The Journal of Immunology. 209(3). 510–525. 13 indexed citations
6.
Silva, Suresh de, George Fromm, Louis Gonzalez, et al.. (2021). Abstract 1736: Antigen-specific targeting of tissue-resident gamma delta T cells with recombinant butyrophilin heterodimeric fusion proteins. Cancer Research. 81(13_Supplement). 1736–1736. 2 indexed citations
7.
Silva, Suresh de, George Fromm, Casey W. Shuptrine, et al.. (2019). CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity. Cancer Immunology Research. 8(2). 230–245. 39 indexed citations
8.
Fromm, George, et al.. (2018). Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 6(1). 149–149. 35 indexed citations
9.
Fromm, George, et al.. (2018). Abstract 5564: Agonist redirected checkpoint, VSIG8-Fc-OX40L, for cancer immunotherapy. Cancer Research. 78(13_Supplement). 5564–5564. 3 indexed citations
10.
Fromm, George, et al.. (2016). Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination. Cancer Immunology Research. 4(9). 766–778. 20 indexed citations
11.
Williams, Lucy H., George Fromm, Nolan G. Gokey, et al.. (2015). Pausing of RNA Polymerase II Regulates Mammalian Developmental Potential through Control of Signaling Networks. Molecular Cell. 58(2). 311–322. 127 indexed citations
12.
13.
Fromm, George, Daniel A. Gilchrist, & Karen Adelman. (2013). SnapShot: Transcription Regulation: Pausing. Cell. 153(4). 930–930.e1. 6 indexed citations
14.
Gilchrist, Daniel A., George Fromm, Gilberto dos Santos, et al.. (2012). Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks. Genes & Development. 26(9). 933–944. 99 indexed citations
15.
Fromm, George, Michael Getman, Kathleen E. McGrath, et al.. (2011). An embryonic stage–specific enhancer within the murine β-globin locus mediates domain-wide histone hyperacetylation. Blood. 117(19). 5207–5214. 8 indexed citations
16.
McGrath, Kathleen E., Jenna M. Frame, George Fromm, et al.. (2011). A transient definitive erythroid lineage with unique regulation of the β-globin locus in the mammalian embryo. Blood. 117(17). 4600–4608. 108 indexed citations
17.
18.
Yang, Se‐Ran, Hongwei Yao, R. Saravanan, et al.. (2008). RelB Is Differentially Regulated by IκB Kinase-α in B Cells and Mouse Lung by Cigarette Smoke. American Journal of Respiratory Cell and Molecular Biology. 40(2). 147–158. 31 indexed citations
19.
Yang, Se‐Ran, Hongwei Yao, Aruna Kode, et al.. (2008). IKKα Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung. American Journal of Respiratory Cell and Molecular Biology. 38(6). 689–698. 74 indexed citations
20.
Goodwin, John A., R.D. Bailey, William T. Pennington, et al.. (2001). Structural and Oxo-Transfer Reactivity Differences of Hexacoordinate and Pentacoordinate (Nitro)(tetraphenylporphinato)cobalt(III) Derivatives. Inorganic Chemistry. 40(17). 4217–4225. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iryna Lebedyeva Breakdown of academic impact, for papers by Jörg Hartkamp Breakdown of academic impact, for papers by Keyi Zhu Breakdown of academic impact, for papers by Joseph Wynne Breakdown of academic impact, for papers by Valgarður Sigurðsson Breakdown of academic impact, for papers by Kiran Nakka Breakdown of academic impact, for papers by Archana Mukhopadhyay Breakdown of academic impact, for papers by Svetlana Stoykova Breakdown of academic impact, for papers by Cheryl McFarlane Breakdown of academic impact, for papers by Sho Kubota
Rankless by CCL
2026